According to GlobalData’s medical device pipeline database, 34 Ophthalmic Lasers devices are in various stages of development globally. GlobalData’s report Ophthalmic Lasers provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 24 are in active development, while the remaining ten are in an inactive stage of development. There are three products in the early stages of development, and the remaining 21 are in the late stages of development.
Ophthalmic Laser devices create a uniform and coherent light which can be continuous or pulsed in treating a wide spectrum of diseases involving both the anterior and posterior segments of the eye for correcting refractive disorders. Excimer lasers, femtosecond lasers and YAG lasers are covered under this category. One unit refers to one Ophthalmic Laser.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Ophthalmic Lasers pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Ophthalmic Lasers devices. Overall, most of these Ophthalmic Lasers pipeline devices are being developed by private entities.
Key players involved in the active development of Ophthalmic Lasers include Lensar, LumiThera, Nova Eye Medical, Praevium Research, Princeton University, Rowiak, Shenzhen Zhongke Weiguang Medical Device Technology, Spire Biophotonics Lifesciences, Stroma Medical and University of Bern.
For a complete picture of the developmental pipeline for Ophthalmic Lasers devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.